Shareholding disclosure

Santhera Pharmaceuticals Holding AG

Declared position

65.39%

Threshold

Crossed downwards

Timeline

Published

23.06.2020

Transaction

16.06.2020

Voting rights breakdown

Voting rights acquired9.23%
Voting rights sold65.39%
Below threshold0%

Notice details

CategorySingle shareholder
ExchangeXSWX

Notification ID

TAK6M00028

Beneficial owner

Santhera Pharmaceuticals Holding AG

Declared address

Santhera Pharmaceuticals Holding AG, Pratteln

(Erwerb und Veräusserung von Aktien am 16. Juni 2020)

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open